Dr. Neal V. Palejwala, MD

Dr. Palejwala practices at Mohave Eye Center - Kingman in Kingman, Arizona.

Dr. Palejwala's NPI, 1871720755, was assigned on June 17, 2009. Dr. Palejwala graduated from Jefferson Medical College of Thomas Jefferson University in 2009. Dr. Palejwala holds Arizona license 50648.

Dr. Palejwala's primary practice is Mohave Eye Center - Kingman, at 2110 Airway Ave, Kingman, AZ 86409 in Mohave County. The practice phone is (928) 753-2106.

Dr. Palejwala's primary practice is Mohave Eye Center - Kingman in Kingman, Arizona. Dmand AI also links Dr. Palejwala to 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Palejwala practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Palejwala's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Palejwala is licensed in Arizona.

CMS data shows 86,277 Medicare services from Dr. Palejwala across 24 procedure codes in 2024, for 2,013 Medicare patients. Medicare paid $6,003,712 for them.

CMS counts 2,013 Medicare patients who saw Dr. Palejwala in 2024. The largest group is 75 to 84, with 832 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Palejwala's median patient age at 75, with 53% women.

In 2024, Dr. Palejwala wrote 1,433 Medicare Part D claims for 434 patients. 56% of them were for generic drugs. CMS names the drug for 1,388 of them, across 14 drugs with 11 or more claims each, at $30,512 in total drug cost. In 2023, CMS named 1,112 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Palejwala for performance year 2024, reported as part of a group. Dr. Palejwala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of cataract surgery by Dr. Palejwala, more than 37% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Palejwala, published from 2011 to 2021. 2012 was the busiest year, with 2. The most frequent topics are Retinal Diseases, Tomography, Optical Coherence and Visual Acuity. Dr. Palejwala has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Palejwala's most frequent co-authors are Harpreet Singh Walia, MD, Justin Thomas Lloyd Baynham, MD and Chris Sheldon Bergstrom, MD.

Dmand AI links Dr. Palejwala to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Hypertensive Retinopathy, Retinal Vasculitis and Retinal Vein Occlusion. Oregon Health and Science University sponsors the most, 3.

CMS Open Payments shows 331 general payments to Dr. Palejwala from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $10,458.

Dr. Palejwala graduated from Jefferson Medical College of Thomas Jefferson University in 2009.